FEB 03, 2022 8:00 AM PST

Violet Extract Boosts Brain Cancer Drug's Performance

WRITTEN BY: Tara Fernandes

Cyclotides are small, ring-shaped proteins produced by plants to defend themselves from certain insect pests and bacteria. Now, scientists say they could also help boost the effectiveness of chemo drugs for treating brain cancer. 

Previous studies have shown that these plant peptides complement other oncology pharmaceuticals—they can improve the performance of doxorubicin against breast cancer cells.

Glioblastoma is a very aggressive and often lethal form of brain cancer—after receiving a diagnosis, patients’ median survival time is around a year. There is only one approved chemotherapy for glioblastoma on the market: a drug called temozolomide, or TMZ. Sadly, half the patients have glioblastomas resistant to TMZ, and the other half can develop resistance relatively early in their treatment cycles.

A recent study provides a light at the end of the tunnel. A combo of cyclotides and TMZ increases the tumor-killing potency of the treatment by up to eight-fold. “Phase contrast microscopy of glioblastoma cells exposed to cyclotides alone and coexposed to TMZ indicated shrunken, granular cells with blebbing, and the most pronounced effects were observed with coexposure treatments of cyclotides and TMZ,” wrote the authors.

The researchers say this is cause for optimism.

“We think we are on a path that could lead to better treatment of glioblastoma in the future,” commented research lead Samantha Gerlach. 

Still, these findings are based on experiments performed in cell culture systems. Validating them in animal models is a critical next step towards understanding the true clinical potential of cyclotide-based treatments in brain cancer patients. 

The problem? Cyclotide-producing plants such as violets produce such minute amounts of the compound. Extracting enough of the chemical to test in animals would require large quantities of violets and a process that could take months.

Unfazed by these obstacles, the team continues with their work to identify better clinical strategies for saving the lives of glioblastoma patients.

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
MAY 20, 2022
Health & Medicine
Second COVID Boosters Not Recommended for All Adults
MAY 20, 2022
Second COVID Boosters Not Recommended for All Adults
In previous studies in Israel, vaccine-induced COVID immunity was reported to decrease as early as three  ...
JUN 14, 2022
Coronavirus
Advances in Latest Coronavirus Research in the 2022 Ongoing Labroots Virtual Event Series
JUN 14, 2022
Advances in Latest Coronavirus Research in the 2022 Ongoing Labroots Virtual Event Series
Labroots hosted its 3rd annual Coronavirus Conference Virtual Event Series on May 4, 2022. The speaker roster for this f ...
JUN 20, 2022
Cell & Molecular Biology
Rethinking What We Know About Blood Cell Formation
JUN 20, 2022
Rethinking What We Know About Blood Cell Formation
An image by Sachin H. Patel/Boston Children's Hospital shows embryonic multipotent progenitor cells in a mouse embryo's ...
JUL 06, 2022
Drug Discovery & Development
Promising New Treatment Strategy for Psoriasis and Psoriatic Arthrtis
JUL 06, 2022
Promising New Treatment Strategy for Psoriasis and Psoriatic Arthrtis
Researchers have identified a new potential strategy for inhibiting inflammation in both psoriasis and psoriatic arthrit ...
AUG 02, 2022
Neuroscience
Could Common Viruses be Triggering Alzheimer's?
AUG 02, 2022
Could Common Viruses be Triggering Alzheimer's?
Recent allegations of research misconduct have called years of Alzheimer's research into question. The controversy surro ...
AUG 03, 2022
Clinical & Molecular DX
Monkeypox Updates: Transmission, Symptoms, and Treatment
AUG 03, 2022
Monkeypox Updates: Transmission, Symptoms, and Treatment
With the 2020 Covid lockdowns still fresh in our minds, the recent outbreak of monkeypox in the United States has many p ...
Loading Comments...